Shrooms in the News: Your psychedelic news roundup
More than a few folks have recently wished out loud for a comprehensive hub for the latest psychedelic news, so I decided to turn that wish into a lovely reality sandwich. Behold, your 2nd installment of Shrooms in the News, a bimonthly roundup of what’s happening on the ground.
Psilocybin & Covid Clinicians
Frontline COVID-19 clinicians who underwent psilocybin-assisted therapy saw a big drop in depression—much more than other treatment options managed to deliver. Here’s a quotation from one of the nurses in the study.
“It gave me this sense that (human) suffering can be transcended and transformed, and that’s our natural state. It seemed like I was creating the suffering I was experiencing … and that letting myself be tied up in in suffering that I created can only detract from the care that I provide to future patients.”
Psilocybin Therapy Relief for Cancer Patients
A new study in Nature Mental Health shows psilocybin therapy can ease anxiety, depression, and other mental health struggles tied to cancer.
A Case Study in Psilocybin & Methamphetamine Addiction
Encouraging news from folks in Australia suggesting that an early case study reveals that psilocybin therapy could help folks with Methamphetamine addiction.
In-Home Psilocybin Treatments for the Terminally Ill?
This one hits close to home. Hear the story of the Oregon facilitators who are fighting for in-home care for the terminally ill.